|
Histology
|
No of samples
|
Sequences
|
Aligned
|
Unique aligned
|
Assigned to miRNAd
|
Assigned to small RNA contigs
|
|---|
|
Normala
|
12
|
137,821,767
|
107,214,046 (77.8 %)
|
69,211,744 (50.2 %)
|
44,584,258
|
361,269,586
|
|
Carcinoma in Situ
b
|
3
|
46,285,700
|
36,839,326 (79.6 %)
|
27,608,395 (59.6 %)
|
24,977,605
|
55,763,124
|
|
Embryonal Carcinoma cell linesc
|
6
|
24,651,693
|
14,504,501 (58.8 %)
|
12,270,382 (49.8 %)
|
4,076,105
|
12,679,068
|
|
Embryonal Carcinoma
|
5
|
60,049,727
|
45,515,442 (75.8 %)
|
22,271,004 (37.1 %)
|
14,412,704
|
21,9138,834
|
|
Yolk Sac Tumor
|
4
|
33,808,192
|
25,482,718 (75.4 %)
|
14,831,132 (43.9 %)
|
15,221,965
|
80,580,426
|
|
Seminoma
|
3
|
24,687,396
|
18,385,722 (74.5 %)
|
12,754,266 (51.7 %)
|
5,327,777
|
52,606,953
|
|
Teratoma
|
3
|
43,576,658
|
35,638,201 (81.8 %)
|
21,503,877 (49.3 %)
|
30,109,084
|
76,746,231
|
|
Chorio-carcinoma
|
1
|
80,68,838
|
6,171,431 (76.5 %)
|
4,171,369 (51.7 %)
|
4,545,330
|
8,955,051
|
|
TOTAL
|
37
|
378,949,971
|
289,751,387 (76.5 %)
|
184,622,169 (48.7 %)
|
143,254,828
|
867,739,273
|
- Raw sequence data from the small RNA sequencing dataset. Percentage >100 % is due to multiple hits in the sequence mapping. aThe normal samples are from 11 healthy men and 1 biopsy from histological normal tissue adjacent to a tumor in a TGCT patient. b The cell line samples consists of cells from the embryonal carcinoma lines NT2 and 2102Ep. c Evaluation of cryosections of the carcinoma in situ samples estimated presence of CIS cells in 10 %, 50 %, and 100 % of the seminiferous tubuli. d As annotated by miRBase
